Muna Therapeutics vs Dataland
Side-by-side comparison of AI visibility scores, market position, and capabilities
Muna Therapeutics raised $75M in 2024 targeting microglial biology in Alzheimer's disease, using iPSC-derived microglia models to identify novel drug targets that modulate brain immune function.
About
Muna Therapeutics focuses on microglial biology — the specialized immune cells of the brain — as the key to developing disease-modifying Alzheimer's therapies beyond amyloid targeting. The company uses induced pluripotent stem cell (iPSC)-derived microglia as disease models to identify and validate novel drug targets implicated by Alzheimer's genetics (TREM2, PLCG2, BIN1, APOE). This platform enables the company to study microglial dysfunction at scale and run drug screens against human-relevant cellular models.
NY no-code collaborative database with workflow automation received M&A offer April 2025; YC W20 $1M revenue competing with Airtable and Notion for business operations teams without SQL expertise.
About
Dataland is a New York-based no-code collaborative data management platform — backed by Y Combinator (W20) with funding from South Park Commons and Switch Ventures — providing business teams with a spreadsheet-like interface for centralizing, structuring, and automating business data workflows without SQL expertise, generating $1 million in revenue in 2024 with a 5-9 person team. Received an M&A offer in April 2025, positioning as a competitive alternative to Airtable and Notion in the growing no-code database market.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.